雙腔起搏器市場：現況分析與預測（2023-2030）

Dual Chamber Pacemakers Market: Current Analysis and Forecast (2023-2030)

出版日期: 2023年12月30日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 152 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

雙腔起搏器是一種特殊的心臟裝置，其導線插入心臟的心房和心室。透過協調心室和心房之間的電訊號，它可以調節心律並提高其有效性。透過同步心房和心室的功能，這些設備旨在重建心臟的自然節律，並在心臟的電氣系統需要幫助時提供支持。其他幾個因素正在推動雙腔起搏器的發展，包括遺傳疾病和不健康生活方式的增加。例如，根據BMC Public Health 的數據，2023 年7 月，不健康生活方式的盛行率分別為86.4% 的飲食、14.5% 的酒精、6.0% 的菸草、72.2% 的體力活動、42.3% 的螢幕時間和63.9% 的睡眠時間。

由於全球菸酒流行率不斷上升，雙腔起搏器市場預計將穩定成長 4.5% 左右。根據 2021 年全國藥物使用與健康調查 (NSDUH)，2020 年有 2,950 萬名 12 歲及以上的人患有酒精使用障礙 (AUD)。在預測期內，有幾個因素正在推動市場成長，包括心臟病發病率的急劇增加、對喉癌的認識不斷提高、吸煙人口的增加、酗酒文化的興起以及對心臟病學的投資增加。我們正在推動。除此之外，透過雙腔起搏器提高治療效率可以加快治療過程並提高精確度，這也穩步推動了雙腔起搏器市場的發展。

依產品類型分為植入式心律調節器和體外心律調節器。由於心律調節器植入數量的增加，2022年植入式心律調節器將佔據全球雙腔心律調節器市場的最大份額。例如，根據西班牙心臟學會的數據，2021年起搏器植入數量較2020年增加了12.8%，較2018-2019年的平均值增加了3%。植入式心律調節器透過手術植入胸部或腹部，並直接連接到心臟，以持續監測和調整心律。它專為長期使用而設計，並提供持續的支援。由於肥胖率上升、人口老化以及吸煙、酗酒和不健康生活習慣等生活方式相關疾病患者數量的增加，該領域正在主導市場。心臟病家族史也是該細分市場的驅動因素。因此，在癌症類型中，植入式心律調節器領域將在2022年佔據很大的市場。

依應用，市場分為心律不整、心搏過緩等。由於人們久坐的生活方式的盛行，預計在預測期內心動過緩部分將佔據很大的市場份額。心搏過緩是心律不整的一種，但並非所有心律不整都涉及心率降低。有些心律不整可能會導致您的心臟跳動過快或不規則，但不一定會減慢心跳速度。該領域是由技術進步所驅動的。例如，根據《美國心臟病學雜誌》報道，2020 年 9 月，全球每 600 人中就有 1 人患有心搏過緩。因此，在所有技術中，心搏過緩類別預計在預測期內複合年增長率最高。

為了更了解雙腔起搏器的市場介紹，將市場分為北美（美國、加拿大等北美地區）、歐洲（德國、英國、法國、西班牙、義大利等）歐洲地區）和亞太地區（根據世界其他地區（中國、日本、印度、亞太其他地區）和世界其他地區的全球影響力進行分析。在目前的2022年情境中，北美因菸霧污染加劇、酒精消費增加以及開發有效雙腔起搏器的投資增加而佔據市場主導地位。例如，根據國家藥物濫用統計中心的數據，在約翰霍普金斯大學-馬裡蘭大學巴爾的摩分校的一項調查中，60.1% 的參與者表示，自2020 年3 月1 日以來，他們增加了飲酒量。政府機構已啟動心臟病意識計劃，為患者提供有效的治療。因此，按地區劃分，北美將在 2022 年佔據較大市場份額。

Double-chamber pacemakers are specialized cardiac devices employing leads inserted into both the atrium and ventricle of the heart. They work by coordinating electrical signals between these chambers, aiding in the regulation of heart rhythm and enhancing its effectiveness. By synchronizing atrial and ventricular functions, these devices aim to replicate the natural rhythm of the heart, providing support when the heart's electrical system requires assistance. Several other factors, such as rising genetic disorders and unhealthy lifestyles are leading drivers of dual-chamber pacemakers globally. For instance, according to the BMC Public Health, in July 2023, the prevalence of unhealthy lifestyles was 86.4% for diet, 14.5% for alcohol, 6.0% for tobacco, 72.2% for physical activity, 42.3% for screen time, and 63.9% for sleep duration.

The Dual Chamber Pacemakers Market is expected to grow at a steady rate of around 4.5% owing to the increased prevalence of alcohol and tobacco globally. According to the 2021 National Survey on Drug Use and Health (NSDUH), 29.5 million people ages 12 and older had Alcohol Use Disorder (AUD) in the year 2020. Several factors, including a surge in the incidence of cardiac disorders, increasing awareness regarding throat cancer, increasing smoking population, rising alcoholism culture, and increased investments in cardiology departments are driving the growth of the market during the forecast period. Apart from this, accelerated treatment efficiency with dual-chamber pacemakers has resulted in faster treatment procedures and better accuracy which is also driving this market of dual-chamber pacemakers at a steady rate.

Based on product type, the market is segmented into implantable pacemakers and external pacemakers. The implantable pacemakers segment held the maximum share in the global market of dual-chamber pacemakers in 2022 owing to the rising number of pacemaker implants performed. For instance, according to the Spanish Society of Cardiology in 2021, there was a 12.8% increase in pacemaker implants compared with 2020 and a 3% increase compared with the average for 2018 to 2019. Implantable pacemakers are surgically implanted into the chest or abdomen, directly connected to the heart, and continuously monitor and regulate the heart's rhythm. They are designed for long-term use and offer ongoing support. This segment dominated the market because of the rising cases of obesity, increasing geriatric population, and increased prevalence of ill lifestyles including smoking, alcoholism, and unhealthy lifestyles among people. A family history of heart disease is also a propelling factor for this segment. Thus, amongst cancer types, the implantable pacemakers segment held a significant share of the market in 2022.

Based on application, the market is categorized into arrhythmias, bradycardia, and others. The bradycardia segment is expected to hold a significant share of the market in the forecast period owing to the prevalent sedentary lifestyle of people. Bradycardia can be a type of arrhythmia, but not all arrhythmias involve a slow heart rate. Some arrhythmias can cause the heart to beat too fast or irregularly without necessarily slowing it down. This segment is propelled by rising technological advancements. For instance, the incidence of bradycardia was reported to be approximately 1 in 600 individuals worldwide in September 2020 according to the American Journal of Cardiology. Thus, amongst technology, the bradycardia category is expected to witness a higher CAGR during the forecast period.

For a better understanding of the market adoption of dual chamber pacemakers, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the increasing smoke pollution, increasing alcohol consumption, and rising number of investments in developing effective dual chamber pacemakers. For example, according to the National Center for Drug Abuse Statistics, in a Johns Hopkins-University of Maryland-Baltimore survey, 60.1% of participants reported drinking more alcohol after March 1, 2020. Government organizations are initiating cardiac disorder awareness programs to provide efficient care to patients. Thus, amongst regions, North America held a significant share of the market in 2022.

Some of the major players operating in the market include: Abbott; Biotronik; Boston Scientific Corporation; Lepu Medical Application (Beijing)Co., Ltd.; LivaNova PLC; MEDICO S.R.L.; Medtronic; Oscor Inc.; OSYPKA MEDICAL; MicroPort Scientific Corporation.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Dual Chamber Pacemakers Market
2.2. Research Methodology of the Dual Chamber Pacemakers Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE DUAL CHAMBER PACEMAKERS MARKET

6 DUAL CHAMBER PACEMAKERS MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY PRODUCT TYPE

7.1. Implantable pacemakers
7.2. External pacemakers

8 MARKET INSIGHTS BY APPLICATION

8.1. Arrhythmias
8.2. Bradycardia
8.3. Others

9 MARKET INSIGHTS BY REGION

9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Rest of North America
9.2. Europe
- 9.2.1. Germany
- 9.2.2. U.K.
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Rest of Europe
9.3. Asia-Pacific
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. India
- 9.3.4. Rest of Asia-Pacific
9.4. Rest of World